Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 956483-02-6, Fv-100 free base, 0nj5f6d4u7, ((2r,3s,5r)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)tetrahydrofuran-2-yl)methyl l-valinate, (s)-((2r,3s,5r)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)tetrahydrofuran-2-yl)methyl 2-amino-3-methylbutanoate, [(2r,3s,5r)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2s)-2-amino-3-methylbutanoate

Molecular Formula

C₂₇H₃₅N₃O₆

Molecular Weight

497.6 g/mol

InChI Key

FJRRWJMFUNGZBJ-RBVMOCNTSA-N

FDA UNII

0NJ5F6D4U7

1 2D Structure

Valnivudine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-amino-3-methylbutanoate

2.1.2 InChI

InChI=1S/C27H35N3O6/c1-4-5-6-7-17-8-10-18(11-9-17)21-12-19-14-30(27(33)29-25(19)36-21)23-13-20(31)22(35-23)15-34-26(32)24(28)16(2)3/h8-12,14,16,20,22-24,31H,4-7,13,15,28H2,1-3H3/t20-,22+,23+,24-/m0/s1

2.1.3 InChI Key

FJRRWJMFUNGZBJ-RBVMOCNTSA-N

2.1.4 Canonical SMILES

CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)C4CC(C(O4)COC(=O)C(C(C)C)N)O

2.1.5 Isomeric SMILES

CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)COC(=O)[C@H](C(C)C)N)O

2.2 Other Identifiers

2.2.1 UNII

0NJ5F6D4U7

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 956483-02-6

2. Fv-100 Free Base

3. 0nj5f6d4u7

4. ((2r,3s,5r)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)tetrahydrofuran-2-yl)methyl L-valinate

5. (s)-((2r,3s,5r)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)tetrahydrofuran-2-yl)methyl 2-amino-3-methylbutanoate

6. [(2r,3s,5r)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2s)-2-amino-3-methylbutanoate

7. Unii-0nj5f6d4u7

8. Valnivudine [inn]

9. Valnivudine [who-dd]

10. Chembl4300944

11. Schembl17709483

12. Dtxsid30241909

13. L-valine 5'-ester With 3-(2-deoxy-beta-d-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3h)-one

14. Hy-109016

15. Cs-0030514

16. Q27237002

17. ((2r,3s,5r)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo(2,3- D)pyrimidin-3(2h)-yl)oxolan-2-yl)methyl L-valinate Antiviral

18. (s)-((2r,3s,5r)-(3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)-tetrahydrofuran-2-yl))methyl 2-amino-3-methylbutanoate

19. (s)-((2r,3s,5r)-(3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2h)-yl)-tetrahydrofuran-2-yl))methyl2-amino-3-methylbutanoate

20. L-valine, 5'-ester With 3-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo(2,3-d)pyrimidin-2(3h)-one

2.4 Create Date

2007-05-22

3 Chemical and Physical Properties

Molecular Formula	C₂₇H₃₅N₃O₆
Molecular Weight	497.6 g/mol
XLogP3	4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	11
Exact Mass	497.25258584 g/mol
Monoisotopic Mass	497.25258584 g/mol
Topological Polar Surface Area	124 Å²
Heavy Atom Count	36
Formal Charge	0
Complexity	905
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Valnivudine manufacturers, exporters & distributors on PharmaCompass

Valnivudine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DIGITAL CONTENT

1 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?